2. Members may only benefit from the exemptions provided in paragraph 1 with respect to judicial and administrative proceedings, including the appointment of a service address or the appointment of an agent within a member`s jurisdiction, if such exemptions are necessary to ensure compliance with laws and regulations that are not inconsistent with the provisions of this agreement and if these practices are not applied in such a way as to constitute a disguised restriction of trade. (d) international intellectual property protection agreements that came into force prior to the ENTRY into force of the WTO agreement, provided that these agreements are notified to the Travel Council and do not constitute arbitrary or unjustified discrimination against nationals of other members. the agreement on trade-related aspects of intellectual property rights (Annex 1C of the World Trade Organization agreement of 15 April 1994); See secretariat of the Agreement, the results of the multilateral trade negotiations of the Uruguay Round, texts 365 and following (1994), www.wto.org/english/docs_e/legal_e/legal_e.htm#wtoagreement (delivered on 25 November 2003). 2. Appropriate measures, to the extent that they are consistent with the provisions of this agreement, may be necessary to prevent abuse of rights by rights holders or the use of practices that unduly restrict trade or affect the international transfer of technology. (a) arising from international agreements on mutual legal assistance or general criminal prosecutions and which are not particularly limited to the protection of intellectual property; Since the TRIPS agreement came into force, it has been criticized by developing countries, scientists and non-governmental organizations. While some of this criticism is generally opposed to the WTO, many proponents of trade liberalization also view TRIPS policy as a bad policy. The effects of the concentration of WEALTH of TRIPS (money from people in developing countries for copyright and patent holders in industrialized countries) and the imposition of artificial shortages on citizens of countries that would otherwise have had weaker intellectual property laws are common bases for such criticisms. Other critics have focused on the inability of trips trips to accelerate the flow of investment and technology to low-income countries, a benefit that WTO members achieved prior to the creation of the agreement. The World Bank`s statements indicate that TRIPS have clearly not accelerated investment in low-income countries, whereas they may have done so for middle-income countries.  As part of TRIPS, long periods of patent validity were examined to determine the excessive slowdown in generic drug entry and competition.
In particular, the illegality of preclinical testing or the presentation of samples to be authorized until a patent expires have been accused of encouraging the growth of certain multinationals and not producers in developing countries. This is likely due to the lack of legal and technical expertise needed to develop legislation to implement flexibility, which has often led developing countries to directly copy intellectual property legislation in industrialized countries or to need technical assistance from the World Intellectual Property Organization (WIPO), which critics such as Coryow say encourages them to introduce stronger intellectual property monopolies. An agreement reached in 2003 relaxed domestic market requirements and allows developing countries to export to other countries with a public health problem as long as exported drugs are not part of a trade or industrial policy.  Drugs exported under such regulations may be packaged or coloured differently to prevent them from affecting the markets of industrialized countries.